143 related articles for article (PubMed ID: 8640671)
1. Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.
Ichikawa D; Hashimoto N; Hoshima M; Yamaguchi T; Sawai K; Nakamura Y; Takahashi T; Abe T; Inazawa J
Cancer; 1996 May; 77(10):2064-9. PubMed ID: 8640671
[TBL] [Abstract][Full Text] [Related]
2. Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast carcinoma.
Tsukamoto F; Miyoshi Y; Koyama H; Watatani M; Sasa M; Shiba E; Takami S; Inazawa J; Noguchi S
Cancer; 2000 Dec; 90(6):373-8. PubMed ID: 11156521
[TBL] [Abstract][Full Text] [Related]
3. [Detection of numerical aberrations in chromosomes by fluorescence in situ hybridization in fine needle aspirates in the preoperative diagnosis of cancer].
Noguchi S; Tsukamoto F; Miyoshi Y; Inaji H; Watatani M; Sasa M; Inazawa J; Takami S
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2127-30. PubMed ID: 10635294
[TBL] [Abstract][Full Text] [Related]
4. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
Kapranos N; Kounelis S; Karantasis H; Kouri E
Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
[TBL] [Abstract][Full Text] [Related]
5. [Interphase cytogenetics of the breast tumors with fluorescence in situ hybridization (FISH) on cytologic preparation--its practice and clinical applications].
Shibuya M; Osamura RY
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):363-7. PubMed ID: 8709938
[TBL] [Abstract][Full Text] [Related]
6. Detection of chromosomal numerical abnormalities in clinical breast tumour fine-needle aspirations by fluorescence in situ hybridisation (FISH): refinement of a method.
Patterson AH; McManus DT; Maxwell P
Br J Biomed Sci; 1998 Mar; 55(1):2-7. PubMed ID: 9684409
[TBL] [Abstract][Full Text] [Related]
7. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
8. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes.
Cajulis RS; Frias-Hidvegi D
Acta Cytol; 1993; 37(3):391-6. PubMed ID: 8388611
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study.
Krishnamurthy S; Zhao L; Hayes K; Glassman AB; Cristofanilli M; Singletary SE; Hunt KK; Kuerer HM; Sneige N
Cancer; 2004 Oct; 102(5):322-7. PubMed ID: 15376199
[TBL] [Abstract][Full Text] [Related]
10. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
[TBL] [Abstract][Full Text] [Related]
11. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aneusomy (chr 1, 11, 17) detected by fluorescence in situ hybridization may be a prognostic factor in breast cancer.
Takehisa M; Sasa M; Bando Y; Hirose T; Morimoto T; Nagao T; Tangoku A
Anticancer Res; 2007; 27(2):1073-8. PubMed ID: 17465246
[TBL] [Abstract][Full Text] [Related]
13. Quantitative FISH by image cytometry for the detection of chromosome 1 imbalances in breast cancer: a novel approach analyzing chromosome rearrangements within interphase nuclei.
Truong K; Guilly MN; Gerbault-Seureau M; Malfoy B; Vielh P; Bourgeois CA; Dutrillaux B
Lab Invest; 1998 Dec; 78(12):1607-13. PubMed ID: 9881960
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
Bozzetti C; Personeni N; Nizzoli R; Guazzi A; Flora M; Bassano C; Negri F; Martella E; Naldi N; Franciosi V; Cascinu S
Cancer; 2003 Oct; 99(5):310-5. PubMed ID: 14579298
[TBL] [Abstract][Full Text] [Related]
15. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer.
Heselmeyer-Haddad K; Chaudhri N; Stoltzfus P; Cheng JC; Wilber K; Morrison L; Auer G; Ried T
Cancer Res; 2002 Apr; 62(8):2365-9. PubMed ID: 11956098
[TBL] [Abstract][Full Text] [Related]
16. Detection of chromosome 1 aberrations by fluorescent in situ hybridization (FISH) in the human breast cancer cell line MCF-7.
Léger I; Thomas M; Ronot X; Brugal G
Anal Cell Pathol; 1993 Sep; 5(5):299-309. PubMed ID: 8217910
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy in breast cancer: a fluorescence in situ hybridization study.
Shackney SE; Singh SG; Yakulis R; Smith CA; Pollice AA; Petruolo S; Waggoner A; Hartsock RJ
Cytometry; 1995 Dec; 22(4):282-91. PubMed ID: 8749778
[TBL] [Abstract][Full Text] [Related]
18. Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies.
Walker LC; Harris GC; Wells JE; Robinson BA; Morris CM
Genes Chromosomes Cancer; 2008 May; 47(5):405-17. PubMed ID: 18273837
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization.
Tsukamoto F; Miyoshi Y; Egawa C; Kasugai T; Takami S; Inazawa J; Noguchi S
Cancer; 2001 Apr; 93(2):165-70. PubMed ID: 11309784
[TBL] [Abstract][Full Text] [Related]
20. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
